These include studies showing induction of depressive-like behavior following IGF-1 deficiency [102], decreased depressive- and anxiety-like behavior after chronic FGF-2 treatment [103], and improved mood function following peripheral BDNF administration [104]. This evidence concerns the gene FGF2 and Anxiety.